Literature DB >> 31043315

The impact of obesity on early postoperative atrial fibrillation burden.

Corina Serban1, Johnmary T Arinze1, Roeliene Starreveld1, Eva A H Lanters1, Ameeta Yaksh2, Charles Kik3, Yalin Acardag1, Paul Knops1, Ad J J C Bogers3, Natasja M S de Groot4.   

Abstract

BACKGROUND: Obesity has been linked to the development of postoperative atrial fibrillation. This study is aimed at investigating the role of body mass index in the evolution of de novo, early postoperative atrial fibrillation by assessing differences between obese and nonobese patients undergoing cardiac surgery.
METHODS: Patients with early de novo postoperative atrial fibrillation were included. Continuous cardiac rhythms were recorded during the first 5 postoperative days in obese (N = 67, 66 ± 9 years; 51 [76%] male) and nonobese (N = 89, 69 ± 9; 75 [84%] male) patients without a history of atrial fibrillation undergoing cardiac surgery. Postoperative atrial fibrillation burden was defined as the ratio between total duration of all atrial fibrillation episodes and total recording time (atrial fibrillation burden, %).
RESULTS: A total of 1191 (median: 5/patient) postoperative atrial fibrillation episodes were identified in the obese group compared with 1218 (median: 4/patient) in the nonobese group. The median duration and number of prolonged (>60 minutes) postoperative atrial fibrillation episodes were higher in obese patients (250 vs 145 minutes, P = .003, and median of 2 vs 1 episode, P = .031). Obesity was associated with a larger early postoperative atrial fibrillation burden (obese patients: median, 7%; interquartile range, 2.5-19.7 vs nonobese patients: median, 3.2%; interquartile range, 0.5-8.8, P = .001) mainly on the third postoperative day (P = .021).
CONCLUSIONS: Obesity predisposes to a larger number of prolonged atrial fibrillation episodes in the early postoperative period after cardiac surgery for coronary artery disease or valvular heart disease. The higher atrial fibrillation burden in the early postoperative period occurred particularly on the third day. Future studies will determine whether obesity prevention may play a key role in reducing the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac surgery; de novo early postoperative atrial fibrillation; obesity

Year:  2019        PMID: 31043315     DOI: 10.1016/j.jtcvs.2019.03.073

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Impact of obesity on post-operative arrhythmias after congenital heart surgery in children and young adults.

Authors:  Andrew E Radbill; Andrew H Smith; Sara L Van Driest; Frank A Fish; David P Bichell; Bret A Mettler; Karla G Christian; Todd L Edwards; Prince J Kannankeril
Journal:  Cardiol Young       Date:  2022-01-06       Impact factor: 1.023

2.  Does overweight really play protective role in elderly patients after cardiac surgery?

Authors:  Zeyi Cheng; Luchen Wang; Xiaogang Sun
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

3.  High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.

Authors:  Hyun-Jung Lee; Eue-Keun Choi; Kyung-Do Han; Da Hye Kim; Euijae Lee; So-Ryoung Lee; Seil Oh; Gregory Y H Lip
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

4.  Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction.

Authors:  Pier Luigi Stefàno; Marco Bugetti; Guido Del Monaco; Gloria Popescu; Paolo Pieragnoli; Giuseppe Ricciardi; Laura Perrotta; Luca Checchi; Roberto Rondine; Sergio Bevilacqua; Carlo Fumagalli; Niccolò Marchionni; Antonio Michelucci
Journal:  J Cardiothorac Surg       Date:  2020-10-15       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.